BEDFORD, MA--(Marketwire - February 1, 2010) - Insulet Corporation (NASDAQ: PODD), the leader in tubing-free insulin pump technology with its OmniPod® Insulin Management System announced plans to release its financial results for the fourth quarter and full year 2009 on Tuesday, February 9, 2010 after the close of the financial markets.

Insulet will also host a conference call at 5:00 p.m. Eastern Time on Tuesday, February 9, 2010 to discuss its fourth quarter and full year 2009 financial results. During the conference call, material information concerning the Company, its operations, strategies and prospects may be discussed.

To listen to the conference call, please dial 800-901-5218 for domestic callers and 617-786-4511 for international callers. The passcode is 78048665. A replay of the conference call will be available two hours after the start of the call through February 16, 2010 by dialing 888-286-8010 (domestic) and 617-801-6888 (international), passcode 95682410. An online archive of the conference call will also be available by accessing the Investor Information section of the company's website at

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA

Contact Information: Contact: Stephanie Marks for Insulet Corporation 877-PODD-IR1 (877-763-3471)